Skip to content

Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations

CompletedNCT03669939
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The overarching plan for TOWER is to develop and test an algorithmic version of the Center for Disease Control Guidelines (CDCG) tailored for a specific primary care setting, the HIV primary care clinic. This CDCG intervention incorporates communication and implementation strategies tailored for the HIV primary care setting, and enabled with technology (an app for use by patients and EMR tools for providers).

Study details

Official title
Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations: Implementing the Centers for Disease Control Guideline (CDC) Guideline in the Primary Care HIV Clinic.
Conditions
Interventions
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
The New York Academy of Medicine
Start date
2018-10-05
Primary completion
2020-09-30
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Attending physician or advance practice provider in one of the Institute of Advanced Medicine (IAM) clinics * Designated PCP for at least 5 patients to whom he/she prescribes opioids * Willing and able to adhere to study procedures including randomization, and refraining from discussion of study procedures with other clinical staff or patients Exclusion Criteria: * Unwillingness to undergo randomization * Plans to leave IAM within the study period.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03669939